Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
105,632,895
-
Total 13F shares
-
56,761,587
-
Share change
-
+1,570,173
-
Total reported value
-
$4,203,831,314
-
Put/Call ratio
-
70%
-
Price per share
-
$74.09
-
Number of holders
-
265
-
Value change
-
+$181,642,965
-
Number of buys
-
124
-
Number of sells
-
142
Institutional Holders of Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) as of Q1 2018
As of 31 Mar 2018 Sarepta Therapeutics, Inc. - Common Stock, $0.0001 par value per share (SRPT) had 265 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 56,761,587 shares of stock of the company.
Largest 10 holders included FMR LLC, BlackRock Inc., VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, FRED ALGER MANAGEMENT INC, JENNISON ASSOCIATES LLC, GILDER GAGNON HOWE & CO LLC, DEUTSCHE BANK AG\, and EAGLE ASSET MANAGEMENT INC.
This table shows 265 institutional shareholders of the security as of 31 Mar 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.